- Low molecular weight heparins and their importance in practice2019 | First Faculty of Medicine
- Low molecular weight heparins2015 | Publication without faculty affiliation
- Low molecular weight heparins - their significance in current practice2011 | Central Library of Charles University, Third Faculty of Medicine
- Long-term low molecular weight heparin protection during pregnancy for the recurrent fetal loss +12008 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Low molecular weight heparins +12008 | Faculty of Medicine in Hradec Králové
- Low molecular weight heparins2008 | First Faculty of Medicine
- Long-term low molecular weight heparin protection during pregnancy for the recurrent fetal loss2008 | Central Library of Charles University
- Monitoring of haemocoagulative changes during long-term doses of low molecular weight heparin during pregnancy2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The usage of low-molecular weight heparin during percutaneous coronary interventions +1Publication without faculty affiliation
- Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma2011 | Faculty of Medicine in Hradec Králové
- Low Molecular Weight Heparins for Thromboprophylaxis during Induction Chemotherapy in Patients with Multiple Myeloma2011 | Publication without faculty affiliation
- Treatment of lower extremity superficial vein thrombosis with low molecular weight heparin2016 | Second Faculty of Medicine
- Laboratory monitoring of the low molecular weight heparin and pentasacharide activityPublication without faculty affiliation
- Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation2022 | Central Library of Charles University
- Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients:safety and efficacy2009 | First Faculty of Medicine
- Influence of Long-Term Thromboprophylaxis With Low-Molecular-Weight Heparin (Enoxaparin) on Changes of Bone Metabolism Markers in Pregnant Women2011 | First Faculty of Medicine
- Low molecular weight heparins - the new standard of the treatment of unstable angina2001 | First Faculty of Medicine
- Are all low molecular weight heparin equal?1999 | Faculty of Medicine in Hradec Králové
- Low molecular weight heparins, their importance for out patient practice2005 | First Faculty of Medicine
- Monitoring of haemocoagulative changes during long-term doses of low molecular weight heparin during pregnancy2009 | Central Library of Charles University
- Monitoring of haemocoagulative changes during long-term doses of low molecular weight heparin during pregnancy2009 | Faculty of Medicine in Pilsen
- Changes of coagulation after single i. v. bolus 0, 75 mg per kg of low molecular weight heparin enoxaparine during PCI - a pharmacokinetic studyPublication without faculty affiliation
- Antithrombotic therapy and prophylaxis in COVID-192020 | Faculty of Medicine in Pilsen
- Low-molecular weight heparin vs. unfractionated heparin during percutaneous coronary interventions +1Publication without faculty affiliation
- The role of low molecular weight heparins in prevention of deep venous thrombosis1996 | First Faculty of Medicine
- Platelet aggregation is different after treatment with low molecular weight heparin and unfractionated heparin during PTCAPublication without faculty affiliation